SCHEMBL8285356

SCHEMBL8285356

Cc1cc2c(cn1)c(=O)c(Nc1ccccc1)c(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.40
CDK4 P11802 1/20 0.38
CCND1 P24385 1/20 0.38
CCND2 P30279 1/20 0.38
CCND3 P30281 1/20 0.38
GAA P10253 3/20 0.37
HPGD P15428 2/20 0.37
MAPK1 P28482 1/20 0.37
CYP1A2 P05177 3/20 0.36
MAT2A P31153 2/20 0.36
AHR P35869 1/20 0.36
BUB1 O43683 1/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CXCR2 P25025 3/20 0.34
TSHR P16473 3/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285354 0.93 GSK3B (0.39) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287541 0.89 GSK3B (0.41) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8286159 0.88 GSK3B (0.39) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287492 0.87 GSK3B (0.40) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL6529785 0.84 SMN1; SMN2 (0.40) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287580 0.84 GSK3B (0.38) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8285349 0.82 GSK3B (0.36) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8358810 0.82 GSK3B (0.36) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8288002 0.82 GSK3B (0.36) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8286206 0.81 NPC1 (0.38) GSK3BGAACYP1A2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed